Literature DB >> 20697983

Remission in rheumatoid arthritis.

Rania M Shammas1, Veena K Ranganath, Harold E Paulus.   

Abstract

With advancing therapeutic options, achieving a state of remission has become the treatment goal in rheumatoid arthritis. Agreeing on what constitutes remission and what measures should be used to assess disease activity has remained a challenge. Multiple remission criteria have been devised and modified, all with different strengths and limitations. A consensus definition of remission will need to be achieved if we are to be able to evaluate outcomes of clinical trials and establish treatment targets for practice. Remission defined as the complete absence of disease currently may not be a realistic therapeutic goal.

Entities:  

Mesh:

Year:  2010        PMID: 20697983      PMCID: PMC2927687          DOI: 10.1007/s11926-010-0121-2

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  34 in total

Review 1.  Defining remission in rheumatoid arthritis: what is it? Does it matter?

Authors:  Howard E Paulus
Journal:  J Rheumatol       Date:  2004-01       Impact factor: 4.666

2.  Remission in rheumatoid arthritis: wishful thinking or clinical reality?

Authors:  Carlos A Sesin; Clifton O Bingham
Journal:  Semin Arthritis Rheum       Date:  2005-12       Impact factor: 5.532

3.  Women with inflammatory polyarthritis have babies of lower birth weight.

Authors:  A P Bowden; J H Barrett; W Fallow; A J Silman
Journal:  J Rheumatol       Date:  2001-02       Impact factor: 4.666

4.  Patterns of clinical remission in select categories of juvenile idiopathic arthritis.

Authors:  Carol A Wallace; Bin Huang; Marcia Bandeira; Angelo Ravelli; Edward H Giannini
Journal:  Arthritis Rheum       Date:  2005-11

5.  Rheumatoid arthritis: can we achieve true drug-free remission in patients with RA?

Authors:  Yvonne P M Goekoop-Ruiterman; Tom W J Huizinga
Journal:  Nat Rev Rheumatol       Date:  2010-02       Impact factor: 20.543

6.  Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard.

Authors:  Alejandro Balsa; Eugenio de Miguel; Concepción Castillo; Diana Peiteado; Emilio Martín-Mola
Journal:  Rheumatology (Oxford)       Date:  2010-01-04       Impact factor: 7.580

7.  Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study.

Authors:  Yaël A de Man; Radboud J E M Dolhain; Fleur E van de Geijn; Sten P Willemsen; Johanna M W Hazes
Journal:  Arthritis Rheum       Date:  2008-09-15

8.  Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries.

Authors:  Tuulikki Sokka; Merete Lund Hetland; Heidi Mäkinen; Hannu Kautiainen; Kim Hørslev-Petersen; Reijo K Luukkainen; Bernard Combe; Humeira Badsha; Alexandros A Drosos; Joe Devlin; Gianfranco Ferraccioli; Alessia Morelli; Monique Hoekstra; Maria Majdan; Stefan Sadkiewicz; Miguel Belmonte; Ann-Carin Holmqvist; Ernest Choy; Gerd R Burmester; Recep Tunc; Aleksander Dimić; Jovan Nedović; Aleksandra Stanković; Martin Bergman; Sergio Toloza; Theodore Pincus
Journal:  Arthritis Rheum       Date:  2008-09

9.  Disease activity level, remission and response in established rheumatoid arthritis: performance of various criteria sets in an observational cohort, treated with anti-TNF agents.

Authors:  Anders Gülfe; Daniel Aletaha; Tore Saxne; Pierre Geborek
Journal:  BMC Musculoskelet Disord       Date:  2009-04-23       Impact factor: 2.362

10.  Remission by composite scores in rheumatoid arthritis: are ankles and feet important?

Authors:  Theresa Kapral; Florian Dernoschnig; Klaus P Machold; Tanja Stamm; Monika Schoels; Josef S Smolen; Daniel Aletaha
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  6 in total

1.  An association study of disease activity score components and patient satisfaction with overall health for early RA patients on non-biologic DMARD therapy.

Authors:  Stephanie A Kovalchik; Christina Charles-Schoeman; Dinesh Khanna; Harold E Paulus
Journal:  Rheumatol Int       Date:  2011-07-30       Impact factor: 2.631

2.  Biologic Disease-Modifying Antirheumatic Drugs in a National, Privately Insured Population: Utilization, Expenditures, and Price Trends.

Authors:  Christopher B Atzinger; Jeff J Guo
Journal:  Am Health Drug Benefits       Date:  2017-02

3.  Effect of Bizhongxiao decoction and its dismantled formulae on IL-1 and TNF levels in collagen-induced arthritis in rat synovial joints.

Authors:  Ya-jing Guo; Jiang Chen; Xin-gui Xiong; Dan Wu; Hao Zhu; Qing-hua Liang
Journal:  Theor Biol Med Model       Date:  2012-11-20       Impact factor: 2.432

4.  Pain, sleep and emotional well-being explain the lack of agreement between physician- and patient-perceived remission in early rheumatoid arthritis.

Authors:  Samina A Turk; Linda A Rasch; Dirkjan van Schaardenburg; Willem F Lems; Marjolein Sanberg; Lilian H D van Tuyl; Marieke M Ter Wee
Journal:  BMC Rheumatol       Date:  2018-06-26

5.  Predictors of flare in rheumatoid arthritis patients with persistent clinical remission/low disease activity: Data from the TARAC cohort.

Authors:  Sumapa Chaiamnuay; Srisakul Jiemjit; Wipatcharin Songdechaphipat; Pongthorn Narongroeknawin; Rattapol Pakchotanon; Paijit Asavatanabodee
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

6.  Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone.

Authors:  Edward C Keystone; Ferdinand C Breedveld; Désirée van der Heijde; Ronald F van Vollenhoven; Paul Emery; Josef S Smolen; Iain Sainsbury; Stefan Florentinus; Hartmut Kupper; Kun Chen; Arthur Kavanaugh
Journal:  RMD Open       Date:  2017-09-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.